Clinical Trial

Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke

Study acronym: INSTANT
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 24, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to assess the safety and efficacy of early administration of tirofiban in patients treated with tenecteplase for acute ischemic stroke.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-11-02.
Status change: Not Yet Recruiting → Recruiting 2025-12-17
Trial Details
NCT Number NCT05604638
Lead Sponsor Second Affiliated Hospital of Guangxi Medical University
Collaborators: Ganzhou City People's Hospital
Conditions Acute Ischemic Stroke
Enrollment 348 participants
Start Date 2024-04-24
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-24